¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"animal identification systems"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • animal model
    µ¿¹°¸ðÇü
  • animal passage
    ´ëÀÌÀ½µ¿¹°Á¢Á¾, µ¿¹°°è´ë
  • animal pole
    µ¿¹°±Ø
  • animal reservoir
    µ¿¹°º´¿ø¼Ò
  • animal scabies
    µ¿¹°¿È
  • animal starch
    µ¿¹°³ì¸»
  • germ-free animal
    ¹«±Õµ¿¹°
  • laboratory animal
    ½ÇÇ赿¹°
  • poikilothermal animal
    º¯¿Âµ¿¹°
  • specific pathogen free animal
    ƯÁ¤¹«º´¿øÃ¼µ¿¹°
  • spinal animal
    ô¼öµ¿¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • animal parasitology
    µ¿¹°±â»ýÃæÇÐ
  • animal passage
    ´ëÀÌÀ½µ¿¹°Á¢Á¾
  • animal pole
    µ¿¹°±Ø
  • animal reservoir
    µ¿¹°º´¿ø¼Ò
  • animal scabies
    µ¿¹°¿È
  • animal starch
    µ¿¹°³ì¸»
  • laboratory animal
    ½ÇÇ赿¹°
  • poikilothermal animal
    º¯¿Âµ¿¹°
  • specific pathogen free animal
    ƯÁ¤¹«º´¿øÃ¼µ¿¹°
  • spinal animal
    ô¼öµ¿¹°
  • tumor bearing animal
    Á¾¾çµ¿¹°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • identification phenomenon
    µ¿ÀϽà Çö»ó
  • identification with the aggressor
    °ø°ÝÀÚ¿ÍÀÇ µ¿ÀϽÃ
  • projective identification
    Åõ»çÀû¡¡µ¿ÀϽÃ
  • animal virus
    µ¿¹°¹ÙÀÌ·¯½º
  • animal experiment
    µ¿¹°½ÇÇè(¡­ãùúÐ)
  • animal graft
    µ¿¹°½ÄÇÇ(¡­½ÄÇÇ).
  • animal oil
    µ¿¹°(¼º) ±â¸§.
  • animal passage
    µ¿¹°Åë°ú.
  • animal pole
    µ¿¹°±Ø
  • animal reservoir
    µ¿¹°º´¿ø¼Ò(ÊÙËÓËôËÛ).
  • animal scabies
    µ¿¹°(ÔÑÚª) ¿È
  • animal starch
    µ¿¹°(¼º) ³ì¸».
  • animal virus
    µ¿¹°¹ÙÀÌ·¯½º.
  • animal, germfree
    ¹«±Õµ¿¹°
  • germ free animal
    ¹«±Õµ¿¹°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • identification
    ½Å¿øÈ®ÀÎ, °³Àνĺ°
  • identification by isolated human tooth
    Ä¡Á¾°¨º°(öÍðúÊüܬ).
  • identification by means of dental arch
    Ä¡±Ã(öÍÏá)¿¡ ÀÇÇÑ ½Äº°.
  • identification kit
    µ¿Á¤°Ë»ç¿ë Ŷ
  • identification of biter
    ±³Àڽĺ°(ÎáíºãÛܬ).
  • identification phenomenon
    µ¿ÀϽà Çö»ó
  • identification with the aggressor
    °ø°ÝÀÚ¿ÍÀÇ µ¿ÀϽÃ
  • lateral identification of tooth
    Ä¡¾ÆÁ¿ìÃø½Äº°(öÍä³ñ§éÓö°ãÛܬ).
  • palm and sole system of identification
    ¼öÀå Á·Àú È®Àιý(â¢íæðëî¼ü¬ìãÛö).
  • palm and sole system of identification
    ¼öÀåÁ·ÀúÈ®Àιý(â¢íæðëî¼ü¬ìãÛö).
  • panel in antibody identification
    Ç×üµ¿Á¤(¿ë)ÆÐ³Î
  • pathological identification
    º´Àû µ¿ÀϽÃ
  • patient identification
    ȯÀÚÈ®ÀÎ
  • penicillin identification
    Æä´Ï½Ç¸°È®ÀÎ
  • projective identification
    Åõ»çÀû¡¡µ¿ÀϽÃ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HMIS hazardous materials identification system; hospital medical information system
ID identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ...
NUI number user identification
OID optimal immunomodulating dose; Organism Identification Number; oxygen insufflation device
PIN product identification number
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
KBS Knowledge-Based Systems
TPS Treatment Planning Systems
AUDIT Alcohol Use Disorder Identification Test
MIS Microbial Identification System
PIR Protein Identification Resource
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cold-blooded animal
    ³ÃÇ÷µ¿¹°
  • control animal
    ´ëÁ¶ µ¿¹°
  • decerebrate animal
    Á¦³ú µ¿¹°
    ´ë³úÀÇ ¾ç¹Ý±¸¿Í ÀϺÎÀÇ ³ú°£ ½Å°æÀýÀ» Á¦°ÅÇÑ µ¿¹°.
  • decerebrated animal
    Á¦³ú µ¿¹°
    Á¦³úÀÇ Ã³Ä¡¸¦ ¹ÞÀº µ¿¹°.
  • experimental animal
    ½ÇÇè µ¿¹°
    ½ÇÇè½Ç¿¡¼­ ½ÇÇè ¿¬±¸ÀÇ Àç·á·Î¼­ »çÀ°ÇÏ´Â µ¿¹°.
  • homothermal animal
    Ç׿ µ¿¹°
    Ç×»ó ü¿ÂÀ» À¯ÁöÇÏ´Â µ¿¹°.
  • Houssay animal
    ÇϿ켼ÀÌ µ¿¹°
    ³úÇϼöü¿Í ÃéÀåÀ» Á¦°ÅÇÑ µ¿¹°.
  • hyperphagic animal
    °ú½Äµ¿¹°
    ½Ã»ó ÇϺÎÀÇ º¹³»Ãø ÇÙÀÇ ¼¼Æ÷°¡ ÆÄ±«µÈ ½ÇÇ赿¹°·Î¼­ °ú½Ä°ú È䯸¼ºÀÌ Æ¯Â¡ÀÌ´Ù.
  • monoestrus animal
    ´Ü¹ßÁ¤¼º µ¿¹°
  • nuclein animal
    ´©Å¬·¹ÀÎ µ¿¹°
    ´©Å¬·¹ÀÎÀ» ÁÖ»çÇÑ µ¿¹°.
  • oblongata animal
    ¿¬¼ö µ¿¹°
  • spinal animal
    ô¼ö µ¿¹°
    ô¼ö°¡ Àý´ÜµÇ¾î ³ú¿ÍÀÇ ¿¬¶ôÀÌ Â÷´ÜµÈ µ¿¹°.
  • thalamic animal
    ½Ã»ó µ¿¹°
    ³ú°£À» ½Ã»óÀÇ ¹Ù·Î À§¿¡¼­ Àý´ÜÇÑ ½ÇÇè µ¿¹°.
  • viviparous animal
    Å»ý µ¿¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
clinical pharmacy information systems Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of clinical pharmacy services.
(12 Dec 1998)
computer systems Systems composed of a computer or computers, peripheral equipment, such as disks, printers, and terminals, and telecommunications capabilities.
(12 Dec 1998)
multi-institutional systems Institutional systems consisting of more than one health facility which have cooperative administrative arrangements through merger, affiliation, shared services, or other collective ventures.
(12 Dec 1998)
point-of-care systems Laboratory and other services provided to patients at the bedside. These include diagnostic and laboratory testing using automated information entry systems.
(12 Dec 1998)
health systems agencies Health planning and resources development agencies which function in each health service area of the united states (pl 93-641).
(12 Dec 1998)
health systems plans Statements of goals for the delivery of health services pertaining to the health systems agency service area, established under pl 93-641, and consistent with national guidelines for health planning.
(12 Dec 1998)
hemic and immune systems The organs involved in the production and functions of the blood and the cellular and molecular components providing defense against foreign organisms or substances.
(12 Dec 1998)
second messenger systems Systems in which an intracellular signal is generated in response to an intercellular primary messenger such as a hormone or neurotransmitter. They are intermediate signals in cellular processes such as metabolism, secretion, contraction, phototransduction, and cell growth. Examples of second messenger systems are the adenyl cyclase-cyclic AMP system, the phosphatidylinositol diphosphate-inositol triphosphate system, and the cyclic GMP system.
(12 Dec 1998)
hospital communication systems The transmission of messages to staff and patients within a hospital.
(12 Dec 1998)
hospital distribution systems Systems for delivering hospital supplies, food, laundry, etc., to patient care areas.
(12 Dec 1998)
hospital information systems Integrated, computer-assisted systems designed to store, manipulate, and retrieve information concerned with the administrative and clinical aspects of providing medical services within the hospital.
(12 Dec 1998)
neurosecretory systems A system of neurons that has the specialised function to produce and secrete hormones, and that constitutes, in whole or in part, an endocrine organ or system.
(12 Dec 1998)
database management systems Software designed to store, manipulate, manage, and control data for specific uses.
(12 Dec 1998)
decision support systems, clinical Computer-based information systems used to integrate clinical and patient information and provide support for decision-making in patient care.
(12 Dec 1998)
decision support systems, management Computer-based systems that enable management to interrogate the computer on an ad hoc basis for various kinds of information in the organization, which predict the effect of potential decisions.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • colonial animal
    ±ºÃ¼ µ¿¹°
  • domestic animal
    °¡Ãà
  • economic animal
    °æÁ¦ µ¿¹°(°æÁ¦ ´ë±¹À¸·Î¼­ÀÇ ÀϺ»À» ¾ßÀ¯Çϴ ȣĪ)
  • pack animal
    Áü ³ª¸£´Â Áü½Â;Áü¸»
  • property animal
    ¿¬±Ø ¿µÈ­¿ëÀ¸·Î ±æµéÀÎ µ¿¹°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á